NexImmune (NEXI) has released an update to notify the public and investors about the submission of matters to a vote of security holders.
The Company has delayed its special meeting initially planned to approve its liquidation and dissolution due to new financing endeavors aimed at enhancing the business’s value and asset worth. They are considering various alternatives and, depending on the results, will announce a new meeting for shareholder approval of the dissolution plan, along with setting a new record date for eligible voting stockholders and submitting necessary documentation to the Securities and Exchange Commission.
For further insights into NEXI corporate activity, check out TipRanks’ Insiders Trading Activity page.
For a comprehensive understanding of the announcement, you can read the full document here.
